Entity family
Named diseases, disorders, syndromes, injuries, and health conditions. Examples include epilepsy, diabetes, stroke.
Showing 1,681–1,740 of 18,081, ordered by supporting articles. Choose a disease to see its evidence.
…Objectives B-cell targeted therapies are increasingly used in systemic lupus erythematosus (SLE). However, real-world evidence on treatment persistence an…
…mia (AIHA) represents a serious haematological manifestation of Systemic Lupus Erythematosus (SLE). Reported prevalence estimates vary widely across studies…
…d, comprising 215 patients (88% female; age range 12–78 years). Discoid lupus erythematosus (DLE) represented the largest subgroup, with complete (n=46/84)…
…ubunit 1, blocks interferon-mediated signaling a key pathway in SLE immunopathogenesis.To describe real-world effectiveness, glucoc…
…72) provide further kidney function maintenance data to support LN treatment decisions.Funding GSK (BEL114054, NCT01639339)Origina…
…e but had a worse survival than BLM used as the first bDMARD in SLE patients.…
… stimulating factor (BlyS), approved in 2011 as a treatment for systemic lupus erythematosus (SLE). We present the experience with BLM in monotherapy in thi…
…y/intolerant SLE, OBZ yielded promising responses, including in lupus nephritis, with acceptable safety. These findings support OBZ as a therap…
… Sleep disturbance is a frequent and underrecognized feature of systemic lupus erythematosus (SLE). The aims of this study are to assess the prevalence of p…
…Objectives Systemic Lupus Erythematosus (SLE) is a heterogenous disease affecting multiple organ system…
…l activity in SLE, with a focus on lupus nephritis (LN).Methods SLE serum consistently induces neutrophil clustering during NET for…
…-American countries). Composite definition of DM for extrarenal SLE: (i) significant reduction in SLEDAI (>3 points), (ii) no sever…